Follow
"Base editing has arrived on the cellular immunotherapy scene, allowing the simultaneous manipulation of numerous genes—and bringing with it promising proof-of-concept data among the first patients who received the technology."
"Base editing has arrived on the cellular immunotherapy scene, allowing the simultaneous manipulation of numerous genes—and bringing with it promising proof-of-concept data among the first patients who received the technology."